Nautilus Biotechnology
(NASDAQ) NAUT
Nautilus Biotechnology Financials at a Glance
Market Cap
$418.29M
Revenue (TTM)
$0.00
Net Income (TTM)
$59.00M
EPS (TTM)
$-0.47
P/E Ratio
-7.07
Dividend
$0.00
Beta (Volatility)
1.67 (High)
Dividend
$0.00
Beta (Volatility)
1.67 (High)
Price
$3.31
Volume
4,945
Open
$3.19
Price
$3.31
Volume
4,945
Open
$3.19
Previous Close
$3.31
Daily Range
$3.17 - $3.38
52-Week Range
$0.62 - $4.31
Dividend
$0.00
Beta (Volatility)
1.67 (High)
Price
$3.31
Volume
4,945
Open
$3.19
Previous Close
$3.31
Daily Range
$3.17 - $3.38
52-Week Range
$0.62 - $4.31
NAUT News
NAUT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nautilus Biotechnology
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
130
CEO
Sujal M. Patel
Website
www.nautilus.bioHeadquarters
Seattle, WA 98102, US
NAUT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-32%
Return on Capital
-36%
Return on Assets
-31%
Earnings Yield
-14.14%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$418.29M
Shares Outstanding
126.56M
Volume
4.95K
Short Interest
0.00%
Avg. Volume
276.83K
Financials (TTM)
Gross Profit
$6.46M
Operating Income
$66.84M
EBITDA
$52.54M
Operating Cash Flow
$50.70M
Capital Expenditure
$1.28M
Free Cash Flow
$51.97M
Cash & ST Invst.
$103.41M
Total Debt
$30.02M
Nautilus Biotechnology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.59M
+75.0%
Gross Margin
0.00%
N/A
Market Cap
$418.29M
N/A
Market Cap/Employee
$3.12M
N/A
Employees
134
N/A
Net Income
$13.78M
+21.7%
EBITDA
$12.19M
-8.5%
Quarterly Fundamentals
Net Cash
$73.39M
-26.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$26.19M
-0.7%
Short Term Debt
$3.83M
-6.5%
Return on Assets
-30.87%
N/A
Return on Invested Capital
-36.49%
N/A
Free Cash Flow
$12.62M
+13.3%
Operating Cash Flow
$12.38M
+13.5%